(2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol | 921199-28-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol
• 英文别名: (2S)-2beta-(Hydroxymethyl)piperidine-3beta,4beta-diol
• CAS: 921199-28-2
• 化学式: C₆H₁₃NO₃
• 分子量: 147.174
• InChiKey: YZNNBIPIQWYLDM-HCWXCVPCSA-N

物化性质

• 沸点：
  315.4±42.0 °C(Predicted)
• 密度：
  1.279±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  72.7
• 氢给体数：
  4
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-(adamantan-1-yl-methoxy)-1-bromo-pentane 、 (2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 (2S,3R,4S)-1-(5-(((3S,5S,7S)-adamantan-1-yl)methoxy)pentyl)-2-(hydroxymethyl)piperidine-3,4-diol
  参考文献：
  名称：

  部分脱氧脱氧野尻霉素衍生物作为葡糖神经酰胺合酶抑制剂的评估

  摘要：

  葡萄糖神经酰胺合酶 (GCS) 是一种已获批准的治疗戈谢病的药物靶点，被认为是对抗其他人类疾病（包括 2 型糖尿病）的有效靶点。临床药物N-丁基脱氧野尻霉素 (Zavesca) 被认为通过模拟其底物神经酰胺来抑制。在这项工作中，我们证明，与该模型中提出的相反，脱氧野尻霉素核心的 C2-羟基对于 GCS 抑制很重要。在这里，我们表明 C6-OH 似乎不那么重要，这可能为开发对其他糖加工酶（特别是作用于葡萄糖神经酰胺的水解酶）具有较低亲和力（与 Zavesca 相比）的 GCS 抑制剂制定指导方针。

  DOI：

  10.1021/ml200050s
• 作为产物：
  描述：

  (2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol hydrochloride 在 Ambersep 900 OH resin 作用下， 以 water-d1 为溶剂， 生成 (2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol
  参考文献：
  名称：

  4-羟基哌啶生物碱的对映体化学酶法合成

  摘要：

  报道了一种有效的化学酶合成法戈明对映体以及顺式和反式-4-羟基哌啶酸的对映体。该合成从商业 δ-戊内酰胺开始，在相应的磷酸乙烯酯的 Pd 催化甲氧基羰基化后，进行烯丙基氧化，得到外消旋 4-羟基四氢吡啶衍生物，总产率为 57%。使用来自南极念珠菌 (Novozym 435) 和洋葱伯克霍尔德菌 (脂肪酶 PS Amano IM) 的固定化脂肪酶，通过酶催化酯化来拆分该产物。后者分别提供 95% 和 94% ee 的相应 R 酯和 S 醇。然后通过立体选择性硼氢化/氧化将 S 醇转化为 L-fagomine 作为关键步骤，并通过立体选择性氢化转化为顺式-(2R,4S)-4-羟基哌啶酸。

  DOI：

  10.1002/ejoc.201000837

文献信息

• Stereoselective Aldol Additions Catalyzed by Dihydroxyacetone Phosphate-Dependent Aldolases in Emulsion Systems: Preparation and Structural Characterization of Linear and Cyclic Iminopolyols from Aminoaldehydes
  作者：Laia Espelt、Teodor Parella、Jordi Bujons、Conxita Solans、Jesús Joglar、Antonio Delgado、Pere Clapés

  DOI：10.1002/chem.200304966

  日期：2003.10.17

  hydroxyl group originating from the aldehyde. Characterization of the resulting iminocyclitols allowed the assessment of the diastereoselectivity of the enzymatic aldol reactions with respect to the N-protected aminoaldehyde. RAMA formed single diastereoisomers from N-Cbz-glycinal and from both enantiomers of N-Cbz-alaninal, while 14 % of the epimeric product was observed from N-Cbz-3-aminopropanal. Diastereoselectivity

  在许多情况下，磷酸二羟丙酮（DHAP）依赖性醛缩酶催化立体选择性醛缩醛加成的潜力受到受体醛在水/共溶剂混合物中的溶解度的限制。在这里，我们展示了乳液体系作为反应介质的效率，该反应介质是I类果糖-1,6-双磷酸醛缩醛醛糖酶（RAMA）和II类重组鼠李糖-1-磷酸醛糖醛缩醛醛糖酶从DHAP催化的DHAP之间的醛醇加成反应和N-苄氧基羰基（N-Cbz）氨基醛。相对于常规DMF /水混合物，乳液的使用将RAMA催化的羟醛转化率提高了三至十倍。无论反应介质如何，RhuA对N-Cbz氨基醛的反应性都比RAMA高。对于（S）-或（R）-Cbz-丙氨酸，RAMA表现出对R对映体的偏爱，而RhuA没有对映体歧视。将如此获得的线性N-Cbz氨基多元醇进行催化的分子内还原胺化，得到相应的亚氨基环醇。在所有检查的情况下，该反应都是非对映选择性的。面部选择性由源自醛的新形成的羟基的立体化学控制。所得亚氨基环醇的表征
• Fructose-6-phosphate Aldolase in Organic Synthesis:  Preparation of <scp>d</scp>-Fagomine, <i>N</i>-Alkylated Derivatives, and Preliminary Biological Assays
  作者：José A. Castillo、Jordi Calveras、Josefina Casas、Montserrat Mitjans、M. Pilar Vinardell、Teodor Parella、Tomoyuki Inoue、Georg A. Sprenger、Jesús Joglar、Pere Clapés

  DOI：10.1021/ol0625482

  日期：2006.12.1

  straightforward two-step chemo-enzymatic synthesis of D-fagomine and some of its N-alkylated derivatives in 51% isolated yield and 99% de. The key step is the FSA-catalyzed aldol addition of simple dihydroxyacetone (DHA) to N-Cbz-3-aminopropanal. The use of FSA greatly simplifies the enzymatic procedures that used dihydroxyacetonephosphate or DHA/esters. Some N-alkyl derivatives synthesized elicited antifungal

  [结构：见正文] D-果糖-6-磷酸醛缩酶（FSA）以51％的分离产率和99％的de介导了D-fagomine及其某些N-烷基化衍生物的新颖，简单的两步化学酶法合成。关键步骤是在N-Cbz-3-氨基丙醛中FSA催化的简单二羟丙酮（DHA）的羟醛加成。FSA的使用大大简化了使用磷酸二羟基丙酮磷酸酯或DHA /酯的酶促程序。合成的一些N-烷基衍生物引起了抗真菌和抗菌活性以及增强的抑制活性，以及​​对β-半乳糖苷酶和α-葡萄糖苷酶的选择性。
• Assessment of Partially Deoxygenated Deoxynojirimycin Derivatives as Glucosylceramide Synthase Inhibitors
  作者：Richard J. B. H. N. van den Berg、Tom Wennekes、Amar Ghisaidoobe、Wilma E. Donker-Koopman、Anneke Strijland、Rolf G. Boot、Gijsbert A. van der Marel、Johannes M. F. G. Aerts、Herman S. Overkleeft

  DOI：10.1021/ml200050s

  日期：2011.7.14

  N-butyldeoxynojirimycin (Zavesca) is thought to inhibit through mimicry of its substrate, ceramide. In this work we demonstrate that, in contrast to what is proposed in this model, the C2-hydroxyl of the deoxynojirimycin core is important for GCS inhibition. Here we show that C6-OH appears of less important, which may set guidelines for the development of GCS inhibitors that have less affinity (in comparison with

  葡萄糖神经酰胺合酶 (GCS) 是一种已获批准的治疗戈谢病的药物靶点，被认为是对抗其他人类疾病（包括 2 型糖尿病）的有效靶点。临床药物N-丁基脱氧野尻霉素 (Zavesca) 被认为通过模拟其底物神经酰胺来抑制。在这项工作中，我们证明，与该模型中提出的相反，脱氧野尻霉素核心的 C2-羟基对于 GCS 抑制很重要。在这里，我们表明 C6-OH 似乎不那么重要，这可能为开发对其他糖加工酶（特别是作用于葡萄糖神经酰胺的水解酶）具有较低亲和力（与 Zavesca 相比）的 GCS 抑制剂制定指导方针。
• Organocatalyzed synthesis of (−)-4-epi-fagomine and the corresponding pipecolic acids
  作者：Jasna Marjanovic、Zorana Ferjancic、Radomir N. Saicic

  DOI：10.1016/j.tet.2015.07.036

  日期：2015.9

  The enantioselective synthesis of 4-epi-fagomine was accomplished starting from dioxanone and Cbz-protected benyzlamine, in 4 steps, with 18% overall yield. The key feature of this synthetic approach is the tactical combination of reactions: organocatalyzed aldolization/reductive amination, which allows for a quick formation of heterocyclic rings with defined absolute configuration of all stereogenic centers. Two hydroxypipecolic acids and a reduced fagomine analogue were also synthesized. (C) 2015 Elsevier Ltd. All rights reserved.
• Docking and SAR studies of d- and l-isofagomine isomers as human β-glucocerebrosidase inhibitors
  作者：Atsushi Kato、Saori Miyauchi、Noriko Kato、Robert J. Nash、Yuichi Yoshimura、Izumi Nakagome、Shuichi Hirono、Hiroki Takahata、Isao Adachi

  DOI：10.1016/j.bmc.2011.04.011

  日期：2011.6

  We report the structure-activity relationship of a series of D-, and L-isofagomine and fagomine isomers as glycosidase inhibitors. Our study revealed that a positive charge at the anomeric position of D-isofagomines enhanced the potency toward beta-glycosidases, while the epimerization at the C3 OH group drastically reduced their inhibitory potency by over three orders of magnitude. Furthermore, D-3,4-di-epi-isofagomine abolished their inhibition activities against all enzymes. L-Isofagomine was also a fairly potent inhibitor of human beta-glucocerebrosidase, with an IC50 value of 8.7 mu M. A molecular docking study revealed that the positions and orientations of the piperidine ring of D-3-epi-isofagomine in the binding site was similar to that of D-isofagomine, while D-3-epi-isofagomine missed the hydrogen bond interactions between Asp127 and the 3-OH group and between Trp179 and the 3-OH group. Furthermore, the top 10 docking models ranked by IFDscore suggested that D-3,4-di-epi-isofagomine can not bind to beta-glucocerebrosidase at a stable interaction mode. These results provide an insight into the structural requirements of isofagomine isomers for developing a new type of pharmacological chaperone for Gaucher disease. (C) 2011 Elsevier Ltd. All rights reserved.